Introduction:

The Delhi High Court has granted a temporary injunction to HCL Corporation Pvt Ltd, one of the promoter companies of the HCL Group, in its trademark infringement case against Healthcare HCL Reference Laboratories & Ors. The plaintiff, HCL Corporation, which owns the ‘HCL’ trademark and its variants, alleged that the defendants had unlawfully used the mark for healthcare services, causing confusion and misleading the public. The Court found a prima facie case of infringement and restrained the defendants from using the impugned trademarks. The matter will next be heard on March 25, 2025.

Arguments of Both Sides:

HCL Corporation, represented by a team of legal counsels, contended that it is the rightful owner of the ‘HCL’ trademark, an acronym derived from Hindustan Computers Limited, which is globally recognized as a pioneer in technology and innovation. The plaintiff highlighted its adoption of the mark for healthcare services in 2012, its extensive use of the trademark across sectors, and its reputation in the market. HCL Corporation argued that the defendants had applied for trademarks similar to ‘HCL Healthcare’ in 2021 on a “proposed to be used” basis and were using identical blue-and-white color combinations for marketing healthcare services. Despite receiving a cease-and-desist notice, the defendants continued using the marks, allegedly aiming to associate themselves with HCL’s goodwill. HCL Corporation claimed this conduct was mala fide and created a deceptive similarity likely to confuse consumers, thereby causing irreparable harm to its brand.

The defendants, despite being served in advance, did not appear before the Court to contest the allegations. In their absence, no specific arguments were presented on their behalf. However, the Court examined the evidence submitted by the plaintiff, including the use of similar marks by the defendants in their marketing material and the non-compliance with the cease-and-desist notice.

Court’s Judgment:

Justice Amit Bansal held that there was a prima facie case of trademark infringement. The Court noted that the defendants’ marks were deceptively similar to HCL Corporation’s trademarks, creating a high likelihood of confusion among consumers. It stated that the balance of convenience lay with HCL Corporation and emphasized that allowing the defendants to continue using the marks would cause irreparable injury to the plaintiff’s reputation and goodwill. Furthermore, the Court observed that public prejudice could arise from the unauthorized use of similar marks, as it could mislead customers into believing there was an association between the parties.

The Court issued an interim injunction restraining the defendants from using the HCL trademarks in any form, including marketing, selling, or providing goods or services under the disputed marks. It directed the defendants to remove all online content, URLs, and posts associated with the impugned trademarks. Summons were issued in the main lawsuit, and the matter was scheduled for the next hearing on March 25, 2025.